Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
Longval T, Leprêtre AC, Ravinet A, Fayard A, Forcade E, Coman T, Redjoul R, Berceanu A, Buchbinder N, Berlie G, Mappoura M, Giannotti F, Chevillon F, Robin M, Peffault de Latour R, Sicre de Fontbrune F; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Longval T, et al. Among authors: lepretre ac. Bone Marrow Transplant. 2024 Mar 9. doi: 10.1038/s41409-024-02202-9. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38461290 No abstract available.
[Transfusion management and immuno-hematological follow-up after allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Xhaard A, Bouton M, Delugin L, Giraud C, Guyon A, Giroux-Lathuile C, Hajjout K, Nicolas P, Peyrard T, Ratie V, Boisnard A, Capelle L, Godin S, Traineau R, Yacoub-Agha I, Leprêtre AC. Xhaard A, et al. Among authors: lepretre ac. Bull Cancer. 2024 Feb;111(2S):S78-S83. doi: 10.1016/j.bulcan.2023.03.004. Epub 2023 Apr 11. Bull Cancer. 2024. PMID: 37055307 French.
Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria.
Prata PH, Galimard JE, Sicre de Fontbrune F, Duval A, Vieira Martins P, Roncelin S, Debureaux PÉ, Lepretre AC, Larcher L, Birsen R, Benhamou Y, Soulier J, Socié G, Fremeaux-Bacchi V, Peffault de Latour R. Prata PH, et al. Among authors: lepretre ac. Blood. 2023 Apr 13;141(15):1812-1816. doi: 10.1182/blood.2022017019. Blood. 2023. PMID: 36626252 Free article.
Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis.
Valade S, Joly BS, Veyradier A, Fadlallah J, Zafrani L, Lemiale V, Launois A, Stepanian A, Galicier L, Fieschi C, Mirouse A, Tudesq JJ, Lepretre AC, Azoulay E, Darmon M, Mariotte E. Valade S, et al. Among authors: lepretre ac. PLoS One. 2021 Aug 3;16(8):e0251216. doi: 10.1371/journal.pone.0251216. eCollection 2021. PLoS One. 2021. PMID: 34343182 Free PMC article. Clinical Trial.
Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
Longval T, Galimard JE, Leprêtre AC, Suarez F, Amiranoff D, Cazaux M, Kaphan E, Michonneau D, Dhedin N, Coman T, Nguyen Quoc S, Peffault de Latour R, Resche-Rigon M, Sicre de Fontbrune F. Longval T, et al. Among authors: lepretre ac. Br J Haematol. 2021 May;193(4):814-826. doi: 10.1111/bjh.17463. Epub 2021 Apr 12. Br J Haematol. 2021. PMID: 33844842 Clinical Trial.
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Loschi M, Porcher R, Barraco F, Terriou L, Mohty M, de Guibert S, Mahe B, Lemal R, Dumas PY, Etienne G, Jardin F, Royer B, Bordessoule D, Rohrlich PS, Fornecker LM, Salanoubat C, Maury S, Cahn JY, Vincent L, Sene T, Rigaudeau S, Nguyen S, Lepretre AC, Mary JY, Corront B, Socie G, Peffault de Latour R. Loschi M, et al. Among authors: lepretre ac. Am J Hematol. 2016 Jun;91(4):366-70. doi: 10.1002/ajh.24278. Am J Hematol. 2016. PMID: 26689746 Free article.
12 results